PA
PTLA

Pinnacle Associates’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Pinnacle Associates’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-473,350
Closed -$3.38M – 712
2020
Q1 		$3.38M Sell
473,350
-44,594
-9% -$556K 0.1% 199
2019
Q4 		$12.4M Sell
517,944
-36,535
-7% -$1.01M 0.27% 103
2019
Q3 		$14.9M Buy
554,479
+139,400
+34% +$3.91M 0.35% 77
2019
Q2 		$11.3M Sell
415,079
-25,884
-6% -$812K 0.26% 108
2019
Q1 		$15.3M Buy
440,963
+89,475
+25% +$2.58M 0.35% 83
2018
Q4 		$6.86M Sell
351,488
-5,827
-2% -$120K 0.18% 151
2018
Q3 		$9.52M Sell
357,315
-2,680
-0.7% -$87.5K 0.2% 139
2018
Q2 		$13.6M Sell
359,995
-65,621
-15% -$2.51M 0.28% 99
2018
Q1 		$13.9M Sell
425,616
-19,060
-4% -$836K 0.27% 97
2017
Q4 		$21.6M Sell
444,676
-47,705
-10% -$2.41M 0.42% 70
2017
Q3 		$26.6M Sell
492,381
-8,655
-2% -$508K 0.49% 61
2017
Q2 		$28.1M Sell
501,036
-25,140
-5% -$1.01M 0.54% 51
2017
Q1 		$20.6M Sell
526,176
-24,240
-4% -$772K 0.39% 72
2016
Q4 		$12.4M Sell
550,416
-30,520
-5% -$596K 0.25% 109
2016
Q3 		$13.2M Sell
580,936
-3,470
-0.6% -$81.5K 0.26% 104
2016
Q2 		$13.8M Buy
+584,406
New +$14.4M 0.3% 94

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Pinnacle Associates's PTLA Position: Q2 2020 in Review

Pinnacle Associates sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 473,350 shares — an estimated $3.38M sold.

Pinnacle Associates first reported a position in PTLA in Q2 2016 and held it in 16 quarters. The position peaked at $28.1M in Q2 2017. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • Pinnacle Associates reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Pinnacle Associates sold 473,350 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $3.38M.
  • Pinnacle Associates first reported a position in Portola Pharmaceuticals, Inc. in Q2 2016 and held it in 16 quarters.
  • Pinnacle Associates's Portola Pharmaceuticals, Inc. position peaked at $28.1M in Q2 2017.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Pinnacle Associates's 13F filing for Q2 2020, filed 14 Aug 2020.